The other shoe has dropped for Theranos. Late Thursday night, the embattled diagnostics company disclosed that it is officially being sanctioned by the Centers for Medicare and Medicaid Services.

In a press release issued at 11:35 p.m. Eastern time, the wounded unicorn said CMS has moved to revoke the CLIA certificate for Theranos’ laboratory in Newark, California. Company executives — mainly founder and CEO Elizabeth Holmes — will be barred from owning, operating or directing a clinical lab for two years once the sanctions take effect 60 days from now.